October 3 - 4, 2019 São Paulo / Brazil

WTC – Sheraton Hotel / São Paulo – Brazil
Av. das Nações Unidas, 12551


Below the agenda for the Global Cardio Oncology Summit 2019.

thursday, oct 3th

7:30 – 8:00 am
Breakfast (provided) & Registration
8:00 - 8:20 am
Opening Session: Welcome and opening remarks

Dr. Roberto Kalil Filho, Brazil
Dr. Ludhmila Hajjar, Brazil
Dr. Daniel Lenihan, USA
Dr. Susan Dent, USA

8:20 - 8:50 am
Plenary Lecture # 1: The evolving field of cardio-oncology: perspectives
Chairs: Dr. Ludhmila Hajjar, Brazil and Roberto Kalil Filho, Brazil

Dr. Daniel Lenihan, USA (30 min)

8:55 – 9:55 am
Session 01. CARDIOTOXICITY - Part I. Left ventricular dysfunction and heart failure in cardio-oncology
Chairs: Dr. Jean-Bernard Durand, USA and Dr. Ludhmila Hajjar, Brazil

a) 8:50a – 9:05a: The use of biomarkers for prediction of cardiotoxicity.
Dr. Daniela Cardinale, ITA (15 min)

b) 09:05a – 9:20a: Clinical phenotypes associated with cardiac injury during cancer therapy.
Dr. Anne Blaes, USA (15 min)

c) 09: 20a – 09:35a: Multimodality imaging to ensure early detection of cardiotoxicity.
Dr. Jennifer Liu, USA (15 min)

d) 09:35a – 09:50a: Prevention and monitoring of cardiac dysfunction in survivors of adult cancers.
Jean-Bernard Durand, USA (15 min)

Discussion 5 minutes

9:55 - 10:10 am
Coffee Break
10:10 - 11:10 am
Part II. Breast Cancer: Cancer Therapy Monitoring and Treatment Planning – What Should We Be Doing to Minimize Cardiotoxic Risk?
Chairs: Dr. Gustavo dos Santos Fernandes, Brazil and Dr. Susan Dent, USA

a) 10:10a – 10:20a: Case presentation.
Dr. Marilia Higuchi, Brazil (10 min)

b) 10:20a – 10:35a: Contemporary cancer therapy and cardiac impact: Are anthracyclines still necessary?
Dr. Christine Brezden-Masley, CAN (15min)

c) 10:35a – 10: 50a: Radiotherapy: What is the cardiovascular risk?
Dr. Samir Abdallah Hanna, Brazil (15min)

d) 10:50a -11:05a: Is there an effective strategy for cardioprotection?
Dr. Ludhmila Hajjar, Brazil (15 min)

Discussion 5 minutes

11:10 - 12:00 am
Session 02. Vascular toxicity associated with oncology treatments
Chairs: Dr. Artur Katz, Brazil and Dr. Ariane Macedo, Brazil

a) 11:10a – 11:20a: Case presentation.
Dr. Carolina Carvalho Silva, Brazil (10 min)

b) 11:20a – 11:35a: Thromboembolism and anticoagulation in cancer patients.
Dr. Chiara Melloni, USA (15 min)

c) 11:35a – 11:50a: Vascular events encountered in cardio-oncology.
Dr. Joerg Herrmann, USA (15 min)

Discussion 10 minutes

12:00 - 1:00 pm
Lunch (provided)
1:00 – 1:45 pm
Session 03. Cardiovascular Risk Alert in Heme Malignancies
Chairs: Dr. Vanderson Rocha, Brazil and Dr. Juliana Pereira, Brazil

a) 01:00p – 01:20p: Stem cell transplant and cardiotoxic exposures: Early and late effects.

b) 01:20p - 01:40p: Multiple myeloma and amyloidosis: New treatments and cardiovascular challenges.
Dr. Daniel Lenihan, USA (20 min)

Discussion 5 minutes

1:45 – 2:45 pm
Session 04. Coronary Artery Disease in Oncology Patients
Chairs: Dr. Cristina Bittar, Brazil and Dr. Jean-Bernard Durand, USA

a) 01:45p – 01:55p: Case presentation.
Dr. Isabela Costa, Brazil (10 min)

b) 01:55p – 02:10p: Intervention in cancer patients: Individualizing the techniques.
Dr. Carlos Campos, Brazil (15 min)

c) 02:10p – 02:25p: Does radiation exposure affect coronary revascularization?
Dr. Anju Nohria, USA (15 min)

d) 02:25p – 02:40p: Cardiotoxicity of 5-Fluoropyrimidines.
Dr. Thomas Suter, GER (15 min)

Discussion 5 minutes

2:45 – 3: 30 pm
Session 05. Valvular disease
Chairs: Dr Joerg Herrmann, USA and Dr. Isabela Costa, Brazil

a) 02:45p - 02:55p: Case presentation.
Dr. Cristina Bittar, Brazil (10 min)

b) 02:55p – 03:10p: Aortic stenosis and transcatheter aortic valve implantation.
Dr. Fabio Sandoli, Brazil (15min)

c) 03:10p - 03:25p: Carcinoid heart disease.
Dr. Ludhmila Abrahão Hajjar, Brazil (15min)

Discussion 5 minutes

3:30 - 3:45 pm
Coffee Break
3:45 - 4:20 pm
Young investigator Competition - top 3 abstracts for presentation
Chairs: Dr. Sebastian Szmit, POL and Dr. Eric Harrison, USA

Discussion 5 minutes

4:20 - 5:10 pm
Thomas Force Lecture
Dr. Joseph Carver, USA (50 min)
5:10 - 6:30 pm

Dr. Ludhmila Hajjar, Brazil
Dr. Alexander Lyon, UK
Dr. Susan Dent, USA

6:30 - 7:30 pm
JACC CO Journal- Meet the Editors Reception

friday, oct 4th

8:00 – 8:15 am
Recap of Day 1 - Opening Remarks and day 1 overview
Presentation of young investigator awards (5 min)
Chairs: Dr. Sebastian Szmit, POL; Dr. Eric Harrison, USA
Dr. Michael Fradley, USA (overview of day 1) (10 min)
8:15 – 8:45 am
Plenary # 2: Immunotherapy and Adverse Cardiac Events: How to recognize and manage
Chairs: Dr. Susan Dent, USA and Dr. Javid Moslehi, USA

Dr. Tomas Neilan, USA (30 min)

8:45 - 09: 40 am
Session 6: New Scientific Advances in Cardio-Oncology
Chairs: Dr. Alexander Lyon, UK and Mr. Carlos Negrão, Brazil

a) 08:45a – 09:00a: Vascular tone and function in tumors.
Dr. Roger Chammas, Brazil (15 min)

b) 09:00a – 09:15a: Cancer cachexia: effects of aerobic training upon skeletal muscle atrophy and metabolism.
Dr. Patricia Chakur Brum, Brazil (15 min)

c) 09:15a – 09:30a: Genetic susceptibility to anthracycline cardiomyopathy – genes and environment.
Dr. Paul Burridge, USA (15 min)

Discussion 10 minutes

09:40 – 10: 00 am
Coffee Break
10:00 – 11:10 am
Session 7. Cardiac Imaging
Chairs: Dr. Cesar Nomura, Brazil, Dr. Bruna Leal, Brazil and Dr. André Almeida, Brazil

a) 10:00a – 10:30a: Debate: Strain for everybody?
  - Yes: Dr. Juan Plana; USA
  - No: Dr. Ronald Witteles, USA
(10 minutes each; 5 min rebuttals; total 30 minutes)

b) 10:30a - 10:45a: Cardiac magnetic resonance – when to use, new protocols.
Dr. Dinesh Thavendiranathan, CAN (15 min)

c) 10:45a – 11:00a: Coronary tomography in cancer patients.
Dr. Carlos Rochitte, Brazil (15 min)

Discussion 10 minutes

11:10 – 12:00 am
Session 8: Research and Training Programs
Chairs: Dr. Joseph Carver, USA and Dr. Carolina Carvalho Silva, Brazil.

a) 11:10a – 11:25a: Fellowships in cardio-oncology.
Dr. Ana Barac, USA (15 min)

b) 11:25a – 11:40a: Building a program.
Dr. Alexander Lyon, UK (15 min)

c) 11:40a – 11:55a: Facilitating international collaboration – roles and future projects.
Dr. Susan Dent, USA (15 min)

Discussion 5 minutes

12:00 - 1:00 pm
Lunch (provided)
1:00 – 1:45 pm
Session 9. Advanced Heart Failure in Cancer Patients
Chairs: Dr. Ludhmila Hajjar, Brazil and Dr. Roberta Saretta, Brazil

a) 01:00p – 01:10p: Case presentation.
Dr. Stéphanie Rizk, Brazil (10 min)

b) 01:10p – 01:25p: Criteria for heart transplantation in cancer patient.
Dr. Mônica Avila, Brazil (15 min)

c) 01:25p – 01:40p: Ventricular assist devices.
Dr. Silvia Ayub Ferreira, Brazil (15 min)

Discussion 5 minutes

1:45 - 2:40 pm
Session 10: Cardiovascular Effects of Tyrosine Kinase Inhibitors for Various Solid and Liquid Tumors
Chairs: Dr. Chiara Melloni, USA

a) 01:45p – 02:00p: Overview of targeted therapy for cancer and possible cardiovascular impact.
Dr. Javid Moslehi, USA (15 min)

b) 02:00p – 02:15p: Cardiovascular toxicities of TKIs for CLL and other B-cell malignancies (BTK inhibitors).
Dr. Michael Fradley, USA (15 min)

c) 02:15p – 02:30p: Cardiovascular toxicities of TKIs for melanoma (BRAF and MEK inhibitors)?
Dr. Rodrigo Munhoz, Brazil (15 min)

Discussion10 minutes

2:40 – 3:00 pm
Coffee Break
3:00 - 3:35 pm
Session 11. Survivorship programs
Chairs: Dr. Veronica Santos, Brazil and Dr. Silvia Moulin Ribeiro Fonseca, Brazil

a) 03:00p – 03:15p: Building a survivorship program.
Dr. Gregory Armstrong, USA (15 min)

b) 03:15p – 03:30p: CVD prevention and treatment during survivorship.
Dr. Kevin Oeffinger, USA (15 min)

Discussion 5 minutes

3:35 – 4:10 pm
Session 12. Physical Activity and Cancer
Chairs: Dr. Cristina Bittar, Brazil

a) 03:35p – 03:50p: Evaluation before exercise programs and exercising during treatment.
Dr. Carlos Negrão, Brazil (15 min)

b) 03:50p – 04:05p: Exercise in the follow up of oncology patients.
Dr. Marilia Higuchi, Brazil (15 min)

Discussion 5 minutes

4:10 – 4:35 pm
Session 13. Social Media in Cardio-Oncology: Impact, Tips and Cautions
Chairs: Dr. Marcio Sommer, Brazil and Dr. Jennifer Liu, USA

Dr. Javid Moslehi, USA (20 min)
Discussion 5 minutes

4:35 – 5:15 pm
Session 14. Future of Cardio-Oncology
Chairs: Dr. Christine Bresden-Masley, CAN; Dr. Dinesh Thavendiranathan, CAN and Dr. Ludhmila Hajjar, Brazil

How do we move forward?
Bonnie Ky, USA (30 min)
Discussion 10 minutes

5:15 – 5:30 pm

Provided by

In collaboration with


Supported By